Angus Chen has joined the firm as a partner in the New York office. Angus was previously at Haug Partners, where he was Chair of Life Sciences. Angus’s practice has focused on pharma and biopharma litigation for clients such as Chiesi, Takeda (Shire and Baxalta) and The Medicines company. He has a Ph.D. from Mt. Sinai School of Medicine in biochemistry. In addition to extensive trial experience in pharma and biopharma cases, Angus has extensive experience in PTAB proceedings, appellate work, and advising clients on patent and regulatory strategies, product lifecycle management, and complex settlement agreements.